<p>Neuronal cultures were treated with siRNAs on days 3–5 in culture then exposed to various concentrations of platins for 72 hours starting on day nine in culture. Cell apoptosis was detected by Annexin-V and PI staining and FACS analyses after cells were grown for 12 days. The left panels show representative fluorescence-activated cell sorting (FACS) for cells treated with various concentrations of cisplatin (A), oxaliplatin (B), or carboplatin (C) and scrambled siRNA (SCsiRNA) or APE1siRNA as indicated. The panels on the right show the quantification of data from five independent harvests. Each column represents the mean ± SEM of the percent of apoptotic cells from cultures treated with SCsiRNA (lightly shaded) or with APE1siRNA (heavy s...
Cisplatin can induce peripheral neuropathy, which is a common complication of anti-cancer treatment ...
<p>(A, B) HT29 cells were treated with oxaliplatin (30 μM) (A) or cisplatin (30 μM) (B) in the prese...
OBJECTIVES: Cisplatin (cisPt) is used as a chemotherapeutic agent for the treatment of a variety of ...
<p>Neuronal cultures were treated with siRNAs on days 3–5 in culture then exposed to various concent...
<p>Neuronal cultures were exposed to siRNAs on days 3-5 in culture then exposed to various concentra...
Although chemotherapy-induced peripheral neuropathy (CIPN) is a dose-limiting side effect of platinu...
<div><p>Although chemotherapy-induced peripheral neuropathy (CIPN) is a dose-limiting side effect of...
<p>Each column represents the mean ± SEM of CGRP release in fmol/well/min for untreated sensory neur...
<p>The top panels show representative Western blots of phospho-H2AX (P-H2AX) and actin from cultures...
<p>The top panels (A) show representative immunohistochemical staining for 8-oxoG DNA adducts in con...
Peripheral neuropathy is one of the major side-effects of the anticancer drug, cisplatin. Although p...
The main dose-limiting side effect of cancer treatment with platinum compounds is peripheral neuroto...
<p>A549Pt and A549cisR cells were treated for 48 hours with 5 μM and 5 μM or 25 μM cisplatin (cisPt)...
Chemotherapy-induced peripheral neuropathy (CIPN) is a potentially debilitating side effect of a num...
Oxaliplatin-based chemotherapy improves the outcomes of metastatic colorectal cancer patients. Its m...
Cisplatin can induce peripheral neuropathy, which is a common complication of anti-cancer treatment ...
<p>(A, B) HT29 cells were treated with oxaliplatin (30 μM) (A) or cisplatin (30 μM) (B) in the prese...
OBJECTIVES: Cisplatin (cisPt) is used as a chemotherapeutic agent for the treatment of a variety of ...
<p>Neuronal cultures were treated with siRNAs on days 3–5 in culture then exposed to various concent...
<p>Neuronal cultures were exposed to siRNAs on days 3-5 in culture then exposed to various concentra...
Although chemotherapy-induced peripheral neuropathy (CIPN) is a dose-limiting side effect of platinu...
<div><p>Although chemotherapy-induced peripheral neuropathy (CIPN) is a dose-limiting side effect of...
<p>Each column represents the mean ± SEM of CGRP release in fmol/well/min for untreated sensory neur...
<p>The top panels show representative Western blots of phospho-H2AX (P-H2AX) and actin from cultures...
<p>The top panels (A) show representative immunohistochemical staining for 8-oxoG DNA adducts in con...
Peripheral neuropathy is one of the major side-effects of the anticancer drug, cisplatin. Although p...
The main dose-limiting side effect of cancer treatment with platinum compounds is peripheral neuroto...
<p>A549Pt and A549cisR cells were treated for 48 hours with 5 μM and 5 μM or 25 μM cisplatin (cisPt)...
Chemotherapy-induced peripheral neuropathy (CIPN) is a potentially debilitating side effect of a num...
Oxaliplatin-based chemotherapy improves the outcomes of metastatic colorectal cancer patients. Its m...
Cisplatin can induce peripheral neuropathy, which is a common complication of anti-cancer treatment ...
<p>(A, B) HT29 cells were treated with oxaliplatin (30 μM) (A) or cisplatin (30 μM) (B) in the prese...
OBJECTIVES: Cisplatin (cisPt) is used as a chemotherapeutic agent for the treatment of a variety of ...